SU1246895A3 - Способ получени производных /1,2,4/ триазол/4,3-а/хиноксалин-4-амина или их солей - Google Patents
Способ получени производных /1,2,4/ триазол/4,3-а/хиноксалин-4-амина или их солей Download PDFInfo
- Publication number
- SU1246895A3 SU1246895A3 SU833653375A SU3653375A SU1246895A3 SU 1246895 A3 SU1246895 A3 SU 1246895A3 SU 833653375 A SU833653375 A SU 833653375A SU 3653375 A SU3653375 A SU 3653375A SU 1246895 A3 SU1246895 A3 SU 1246895A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- triazole
- quinoxaline
- ethyl
- chloro
- mol
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 16
- 150000003839 salts Chemical class 0.000 title claims description 6
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 claims description 227
- 150000003852 triazoles Chemical class 0.000 claims description 55
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 43
- 150000001875 compounds Chemical class 0.000 claims description 15
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical class C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 claims description 13
- 229910052739 hydrogen Inorganic materials 0.000 claims description 10
- 239000001257 hydrogen Substances 0.000 claims description 8
- 229920006395 saturated elastomer Polymers 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 238000005917 acylation reaction Methods 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 239000000460 chlorine Substances 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 230000010933 acylation Effects 0.000 claims description 2
- 150000008064 anhydrides Chemical class 0.000 claims description 2
- 150000008282 halocarbons Chemical group 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims 4
- 239000003960 organic solvent Substances 0.000 claims 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 125000001589 carboacyl group Chemical group 0.000 claims 3
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- OXIFSRBTDOYQIK-UHFFFAOYSA-N 2h-quinoxalin-1-amine Chemical compound C1=CC=C2N(N)CC=NC2=C1 OXIFSRBTDOYQIK-UHFFFAOYSA-N 0.000 claims 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 150000008065 acid anhydrides Chemical class 0.000 claims 1
- 238000005576 amination reaction Methods 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 125000003884 phenylalkyl group Chemical group 0.000 claims 1
- 125000004193 piperazinyl group Chemical group 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
- PDOPFYRTIVSUKL-UHFFFAOYSA-N 4-(azepan-1-yl)-[1,2,4]triazolo[4,3-a]quinoxaline Chemical compound C1CCCCCN1C1=NC2=CC=CC=C2N2C1=NN=C2 PDOPFYRTIVSUKL-UHFFFAOYSA-N 0.000 description 57
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 49
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 39
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 35
- 239000000047 product Substances 0.000 description 34
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 32
- 239000000203 mixture Substances 0.000 description 32
- 238000001914 filtration Methods 0.000 description 31
- 239000002244 precipitate Substances 0.000 description 29
- 238000001819 mass spectrum Methods 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- -1 quinoxaline Isopropylamine Chemical compound 0.000 description 22
- 239000011541 reaction mixture Substances 0.000 description 20
- 238000001953 recrystallisation Methods 0.000 description 20
- 238000002360 preparation method Methods 0.000 description 18
- 241000700159 Rattus Species 0.000 description 17
- 239000000243 solution Substances 0.000 description 17
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- 239000007787 solid Substances 0.000 description 13
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 12
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- 239000012043 crude product Substances 0.000 description 8
- 239000007789 gas Substances 0.000 description 8
- 239000011780 sodium chloride Substances 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 6
- ATHHXGZTWNVVOU-UHFFFAOYSA-N N-methylformamide Chemical compound CNC=O ATHHXGZTWNVVOU-UHFFFAOYSA-N 0.000 description 6
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 6
- 230000001430 anti-depressive effect Effects 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 5
- 239000000935 antidepressant agent Substances 0.000 description 5
- 239000002274 desiccant Substances 0.000 description 5
- 238000001704 evaporation Methods 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 5
- 150000003252 quinoxalines Chemical class 0.000 description 5
- BIYSERXJEYOAIY-UHFFFAOYSA-N 4-chloro-1,2,4-triazole Chemical compound ClN1C=NN=C1 BIYSERXJEYOAIY-UHFFFAOYSA-N 0.000 description 4
- IJPKRUJBKUHTKH-UHFFFAOYSA-N CCN1CN(C=N1)Cl Chemical compound CCN1CN(C=N1)Cl IJPKRUJBKUHTKH-UHFFFAOYSA-N 0.000 description 4
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 4
- 229940005513 antidepressants Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
- 235000019341 magnesium sulphate Nutrition 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- FGWYWKIOMUZSQF-UHFFFAOYSA-N 1,1,1-triethoxypropane Chemical compound CCOC(CC)(OCC)OCC FGWYWKIOMUZSQF-UHFFFAOYSA-N 0.000 description 3
- IJQSRRLTMKBAGP-UHFFFAOYSA-N CCN1CN(N)C=N1 Chemical compound CCN1CN(N)C=N1 IJQSRRLTMKBAGP-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000011717 all-trans-retinol Substances 0.000 description 3
- 235000019169 all-trans-retinol Nutrition 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 229940098779 methanesulfonic acid Drugs 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 238000000967 suction filtration Methods 0.000 description 3
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 2
- IBUMUBQOWFBTFU-UHFFFAOYSA-N 1-ethyl-1,2,4-triazol-3-amine Chemical compound CCN1C=NC(N)=N1 IBUMUBQOWFBTFU-UHFFFAOYSA-N 0.000 description 2
- FZZMTSNZRBFGGU-UHFFFAOYSA-N 2-chloro-7-fluoroquinazolin-4-amine Chemical compound FC1=CC=C2C(N)=NC(Cl)=NC2=C1 FZZMTSNZRBFGGU-UHFFFAOYSA-N 0.000 description 2
- JDIPHBYZUMQFQV-UHFFFAOYSA-N 5-ethyl-1h-1,2,4-triazole Chemical compound CCC1=NC=NN1 JDIPHBYZUMQFQV-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- FDWWACRWPQDHDX-UHFFFAOYSA-N CC(C)N(C1)N=CN1Cl Chemical compound CC(C)N(C1)N=CN1Cl FDWWACRWPQDHDX-UHFFFAOYSA-N 0.000 description 2
- VXYNUCOLJIETBZ-UHFFFAOYSA-N CCN(C1)N=CN1NC(C)=O Chemical compound CCN(C1)N=CN1NC(C)=O VXYNUCOLJIETBZ-UHFFFAOYSA-N 0.000 description 2
- CJOLNRGADHRZLR-UHFFFAOYSA-N N1=CC=NC2=CC=CC=C12.CS(=O)(=O)O Chemical compound N1=CC=NC2=CC=CC=C12.CS(=O)(=O)O CJOLNRGADHRZLR-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 150000003927 aminopyridines Chemical class 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- NFSSJGIUWDEDGU-UHFFFAOYSA-N n-ethyl-1h-1,2,4-triazol-5-amine Chemical compound CCNC=1N=CNN=1 NFSSJGIUWDEDGU-UHFFFAOYSA-N 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- FKRCODPIKNYEAC-UHFFFAOYSA-N propionic acid ethyl ester Natural products CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- 231100000048 toxicity data Toxicity 0.000 description 2
- LZTSCEYDCZBRCJ-UHFFFAOYSA-N 1,2-dihydro-1,2,4-triazol-3-one Chemical compound OC=1N=CNN=1 LZTSCEYDCZBRCJ-UHFFFAOYSA-N 0.000 description 1
- FEOIYPLRWRCSMS-UHFFFAOYSA-N 1-ethyl-1,2,4-triazole Chemical compound CCN1C=NC=N1 FEOIYPLRWRCSMS-UHFFFAOYSA-N 0.000 description 1
- NFJQDGNCJJPQNV-UHFFFAOYSA-N 2,3-dichloro-6-methoxyquinoxaline Chemical compound N1=C(Cl)C(Cl)=NC2=CC(OC)=CC=C21 NFJQDGNCJJPQNV-UHFFFAOYSA-N 0.000 description 1
- OTPOUTSRTGLMKE-UHFFFAOYSA-N 2,4-dimethyl-3h-1,2,4-triazol-5-amine Chemical compound CN1CN(C)C(N)=N1 OTPOUTSRTGLMKE-UHFFFAOYSA-N 0.000 description 1
- WKHZLRADDUHIIV-UHFFFAOYSA-N 2,6,7-trichloroquinoxaline Chemical compound C1=C(Cl)C(Cl)=CC2=NC(Cl)=CN=C21 WKHZLRADDUHIIV-UHFFFAOYSA-N 0.000 description 1
- KWVPFECTOKLOBL-KTKRTIGZSA-N 2-[(z)-octadec-9-enoxy]ethanol Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCO KWVPFECTOKLOBL-KTKRTIGZSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- WLMGJKHYCIOYTF-UHFFFAOYSA-N CC(C)NN(C1)C=NN1C(F)(F)F Chemical compound CC(C)NN(C1)C=NN1C(F)(F)F WLMGJKHYCIOYTF-UHFFFAOYSA-N 0.000 description 1
- RQNYFINBKGVECJ-UHFFFAOYSA-N CCN(C1)N=CN1NC Chemical compound CCN(C1)N=CN1NC RQNYFINBKGVECJ-UHFFFAOYSA-N 0.000 description 1
- HPENMYGLQDXTKN-UHFFFAOYSA-N CCN(CC)N(C1)C=NN1C1=CC=CC=C1 Chemical compound CCN(CC)N(C1)C=NN1C1=CC=CC=C1 HPENMYGLQDXTKN-UHFFFAOYSA-N 0.000 description 1
- NYDMMJHMPMKVFQ-UHFFFAOYSA-N CCN(CC)N1C=NN(C)C1 Chemical compound CCN(CC)N1C=NN(C)C1 NYDMMJHMPMKVFQ-UHFFFAOYSA-N 0.000 description 1
- HHDGIGITQMTRCN-UHFFFAOYSA-N CCN1CN(C=N1)NC(C)C Chemical compound CCN1CN(C=N1)NC(C)C HHDGIGITQMTRCN-UHFFFAOYSA-N 0.000 description 1
- DCQDYDSIQUCFPN-UHFFFAOYSA-N CN1CN(C=N1)Cl Chemical compound CN1CN(C=N1)Cl DCQDYDSIQUCFPN-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 241001024304 Mino Species 0.000 description 1
- UILPETBDKSYFTQ-UHFFFAOYSA-N N,N-dimethyl-1,2,4-triazol-4-amine Chemical compound CN(C)N1C=NN=C1 UILPETBDKSYFTQ-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000010340 Sleep Deprivation Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- JQHGLMJLABTXOL-UHFFFAOYSA-N [1,2,4]triazolo[4,3-a]quinoxalin-4-amine Chemical class NC1=NC2=CC=CC=C2N2C1=NN=C2 JQHGLMJLABTXOL-UHFFFAOYSA-N 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 239000000538 analytical sample Substances 0.000 description 1
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 231100000749 chronicity Toxicity 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- WEHWNAOGRSTTBQ-UHFFFAOYSA-N dipropylamine Chemical compound CCCNCCC WEHWNAOGRSTTBQ-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000010907 mechanical stirring Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- YCLCRQTUXHAOQR-UHFFFAOYSA-N n-(1,2,4-triazol-4-yl)acetamide Chemical compound CC(=O)NN1C=NN=C1 YCLCRQTUXHAOQR-UHFFFAOYSA-N 0.000 description 1
- IRALXNALLZVECH-UHFFFAOYSA-N n-ethyl-1,2,4-triazol-4-amine Chemical compound CCNN1C=NN=C1 IRALXNALLZVECH-UHFFFAOYSA-N 0.000 description 1
- XEMZRAAZIMXEEO-UHFFFAOYSA-N n-propan-2-yl-1,2,4-triazol-4-amine Chemical compound CC(C)NN1C=NN=C1 XEMZRAAZIMXEEO-UHFFFAOYSA-N 0.000 description 1
- VIRDKQPLXDNTFG-UHFFFAOYSA-N n-propyl-1h-1,2,4-triazol-5-amine Chemical compound CCCNC1=NC=NN1 VIRDKQPLXDNTFG-UHFFFAOYSA-N 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 239000011356 non-aqueous organic solvent Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43477182A | 1982-10-18 | 1982-10-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU1246895A3 true SU1246895A3 (ru) | 1986-07-23 |
Family
ID=23725622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU833653375A SU1246895A3 (ru) | 1982-10-18 | 1983-10-17 | Способ получени производных /1,2,4/ триазол/4,3-а/хиноксалин-4-амина или их солей |
Country Status (17)
| Country | Link |
|---|---|
| JP (1) | JPS5989684A (enExample) |
| KR (1) | KR860001493B1 (enExample) |
| CA (1) | CA1207772A (enExample) |
| CS (1) | CS248711B2 (enExample) |
| DD (1) | DD215545A5 (enExample) |
| ES (1) | ES526533A0 (enExample) |
| FI (1) | FI74011C (enExample) |
| GR (1) | GR78952B (enExample) |
| IN (1) | IN160956B (enExample) |
| NO (1) | NO160142C (enExample) |
| NZ (1) | NZ205986A (enExample) |
| PH (1) | PH19080A (enExample) |
| PL (1) | PL141382B1 (enExample) |
| PT (1) | PT77507B (enExample) |
| SU (1) | SU1246895A3 (enExample) |
| YU (1) | YU43331B (enExample) |
| ZA (1) | ZA837691B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2552114C2 (ru) * | 2010-09-16 | 2015-06-10 | Хатчисон Медифарма Лимитед | Конденсированные гетероарилы и их применение |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4707261B2 (ja) * | 2001-05-15 | 2011-06-22 | 日本エンバイロケミカルズ株式会社 | キノキサリン系化合物および工業用殺菌組成物 |
| JP4529535B2 (ja) * | 2004-04-30 | 2010-08-25 | 住友化学株式会社 | ４−アミノ［１，２，４］トリアゾロ［４，３−ａ］キノキサリン化合物の殺菌用途 |
| KR101555384B1 (ko) * | 2006-12-13 | 2015-09-23 | 아스카 세이야쿠 가부시키가이샤 | 퀴녹살린 유도체 |
| KR20110095857A (ko) * | 2008-09-10 | 2011-08-25 | 칼립시스, 인코포레이티드 | 질환의 치료를 위한 히스타민 수용체의 헤테로시클릭 억제제 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4008322A (en) * | 1975-06-10 | 1977-02-15 | Eli Lilly And Company | Triazolo(4,3-a)quinoxalines for control of rice |
-
1983
- 1983-09-21 IN IN653/DEL/83A patent/IN160956B/en unknown
- 1983-10-13 CS CS837528A patent/CS248711B2/cs unknown
- 1983-10-13 GR GR72683A patent/GR78952B/el unknown
- 1983-10-14 PT PT77507A patent/PT77507B/pt not_active IP Right Cessation
- 1983-10-14 YU YU2074/83A patent/YU43331B/xx unknown
- 1983-10-14 CA CA000439039A patent/CA1207772A/en not_active Expired
- 1983-10-17 NO NO833770A patent/NO160142C/no unknown
- 1983-10-17 PH PH29702A patent/PH19080A/en unknown
- 1983-10-17 DD DD83255716A patent/DD215545A5/de not_active IP Right Cessation
- 1983-10-17 FI FI833781A patent/FI74011C/fi not_active IP Right Cessation
- 1983-10-17 NZ NZ205986A patent/NZ205986A/en unknown
- 1983-10-17 SU SU833653375A patent/SU1246895A3/ru active
- 1983-10-17 ZA ZA837691A patent/ZA837691B/xx unknown
- 1983-10-17 ES ES526533A patent/ES526533A0/es active Granted
- 1983-10-18 JP JP58195126A patent/JPS5989684A/ja active Granted
- 1983-10-18 PL PL1983244194A patent/PL141382B1/pl unknown
- 1983-10-18 KR KR1019830004929A patent/KR860001493B1/ko not_active Expired
Non-Patent Citations (1)
| Title |
|---|
| Бюлер К кие синтезы. с. 504-505. Г547 СПОСОБ ПОЛУЧЕНИЯ ПРОИЗВОДНЫХ * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2552114C2 (ru) * | 2010-09-16 | 2015-06-10 | Хатчисон Медифарма Лимитед | Конденсированные гетероарилы и их применение |
Also Published As
| Publication number | Publication date |
|---|---|
| NZ205986A (en) | 1986-06-11 |
| ZA837691B (en) | 1985-05-29 |
| KR860001493B1 (ko) | 1986-09-27 |
| ES8504197A1 (es) | 1985-04-01 |
| ES526533A0 (es) | 1985-04-01 |
| FI833781L (fi) | 1984-04-19 |
| PT77507A (en) | 1983-11-01 |
| FI74011B (fi) | 1987-08-31 |
| FI833781A0 (fi) | 1983-10-17 |
| JPS5989684A (ja) | 1984-05-23 |
| CS248711B2 (en) | 1987-02-12 |
| IN160956B (enExample) | 1987-08-22 |
| KR840006485A (ko) | 1984-11-30 |
| YU43331B (en) | 1989-06-30 |
| NO160142B (no) | 1988-12-05 |
| DD215545A5 (de) | 1984-11-14 |
| PH19080A (en) | 1985-12-19 |
| YU207483A (en) | 1986-02-28 |
| FI74011C (fi) | 1987-12-10 |
| GR78952B (enExample) | 1984-10-02 |
| PL141382B1 (en) | 1987-07-31 |
| JPH039915B2 (enExample) | 1991-02-12 |
| PT77507B (en) | 1986-05-28 |
| NO160142C (no) | 1989-03-15 |
| CA1207772A (en) | 1986-07-15 |
| PL244194A1 (en) | 1985-03-26 |
| NO833770L (no) | 1984-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4719047A (en) | Anthracene derivatives | |
| KR100812586B1 (ko) | P38 키나아제 저해제로서 유용한 퀴나졸린 화합물 | |
| US5221681A (en) | Substituted benzoxazepines and benzothiazepines | |
| CZ299248B6 (cs) | Zpusob prípravy olanzapinu a meziprodukty k této príprave | |
| PL119501B1 (en) | Process for manufacturing novel,condensed pyrimidine derivatives pirimidina | |
| SU969165A3 (ru) | Способ получени конденсированных пиримидинов или их солей,или их оптических изомеров | |
| KR20050061490A (ko) | 티에노피롤 유도체의 제조 방법과 중간체 | |
| RU2162470C2 (ru) | 2,7-замещенные производные октагидропирроло[1,2-а]пиразина, способ лечения, фармацевтическая композиция, промежуточные соединения | |
| US4567177A (en) | Imidazoline derivatives as α2 -antagonists | |
| SU1246895A3 (ru) | Способ получени производных /1,2,4/ триазол/4,3-а/хиноксалин-4-амина или их солей | |
| KR20120091088A (ko) | 4,5,6,7-테트라클로로-3'',6''-다이하이드록시-2'',4'',5'',7''- 테트라요오도-3ｈ-스피로［이소벤조푸란-1,9''-잔텐］-3-온(로즈 벤갈) 및 관련 잔텐의 합성 방법 | |
| SA91110352B1 (ar) | عملية محسنة لتحضير مشتقات اندولون مستبدلة | |
| US4753950A (en) | Fused heterocyclic tetrahydroaminoquinolinols and related compounds | |
| BG99359A (bg) | Тетрациклинени съединения,метод и междинни съединения за тяхното получаване и прилагането им като антитуморни агенти | |
| CA1173445A (en) | Quinolone derivatives and their use as pharmaceuticals | |
| FI78084C (fi) | Foerfarande foer framstaellning av nya, terapeutiskt verksamma bensopyranderivat. | |
| IE55900B1 (en) | Imidazo(1,2-a)pyrimidines | |
| Monge et al. | About the synthesis of [1, 2] diazepinoindole derivatives from ethyl 2‐(1‐methylindole) acetate, 2‐indole and 3‐indoleacetohydrazones | |
| US4495187A (en) | Method of using [1,2,4]triazolo[4,3-a]quinoxaline-4-amine derivatives as antidepressant and antifatigue agents | |
| JP2000504352A (ja) | ハロアルコキシ基を含有するピロロ［３，２―ｃ］キノリン誘導体及び薬学的に許容されるその塩 | |
| US4017499A (en) | 6H(1)-Benzopyrano(3,2-c)quinolines | |
| JP2815150B2 (ja) | 置換されたジベンゾシクロヘプテンイミン | |
| US4547501A (en) | Method of using [1,2,4]triazolo[4,3-a]quinoxaline-4-amine derivatives as antidepressant and antifatigue agents | |
| US4020083A (en) | 5-(2-Aminophenyl)-s-triazoles | |
| DE3017564A1 (de) | Geminale dihalogenderivate kondensierter pyrimidin-4-on-verbindungen, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische kompositionen |